MarginsXMarginsX
Home › Markets › Health Care › WST

West Pharmaceutical Services Inc. (WST)

WST trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$417.80
+0.33% on the day
Market cap
$29.1B
Large cap
Revenue · 2025
$3.1B
+6.3% on 2024
Net income · 2025
$493.7M
16.1% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/105770/000010577026000010/0000105770-26-000010-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerWST on NYSE
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000105770
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inPA

Financials · 2025

LineValue
Revenue$3.1B
Net income$493.7M
Operating income$584.9M
Net margin16.1%
Operating margin19.0%
Revenue growth+6.3%
Cash$791.3M
Total assets$4.3B
P/E (computed)59.0×
P/S (computed)9.5×

Warning signs

Cash runway
Cash-flow positive
$464.1M cash at September 30, 2026
Share count, 1 year
-3.2%
2025-10-20 to 2026-10-21 · -5.9% over 3 years
Going-concern doubt
No
10-Q filed October 29, 2026
Insider net buying, 12 months
-$6.6M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-10-29
Cash and burn$464.1M cash; operating cash flow $163.6M a quarter.Report 2026-09-30
Shares outstanding69,661,036 (2026-10-21); 71,943,412 a year earlier; 73,989,670 three years earlier.Cover page 2026-10-21
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Philadelphia, Pennsylvania, United StatesPCAOB Form AP 2026-03-05
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $6.6M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$874.5M$214.0M$189.5M$464.1M$202.9M$3.4B10-Q 2026-10-29
Q2 2026
2026-06-30
$872.3M$154.0M$124.0M$435.8M$202.9M$3.3B10-Q 2026-07-23
Q1 2026
2026-03-31
$844.9M$138.8M$89.9M$521.4M$202.8M$3.2B10-Q 2026-04-23
Q4 2025
2025-12-31
$805.0M$132.1M$251.1M$791.3M$202.8M$3.1B10-K 2026-02-17
Q3 2025
2025-09-30
$804.6M$140.0M$197.2M$628.5M$202.7M$3.0B10-Q 2026-10-29
Q2 2025
2025-06-30
$766.5M$131.8M$177.1M$509.7M$202.6M$3.0B10-Q 2026-07-23
Q1 2025
2025-03-31
$698.0M$89.8M$129.4M$404.2M$202.6M$2.9B10-Q 2026-04-23
Q4 2024
2024-12-31
$748.8M$130.1M$190.1M$484.6M$202.6M$2.9B10-K 2026-02-17

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest annual report10-K2026-02-17
Latest quarterly / interim10-Q2026-10-29
Latest current report8-K2026-10-29
Latest proxyDEFA14A2026-03-12

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+4.2%
1 month+12.0%
3 months+20.3%
Year to date+51.3%
1 year+56.2%
From 52-week high-0.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
DXCMDexCom Inc.$81.61-2.06%$30.4B
RMDResMed Inc.$238.19-0.56%$33.5B
MDLNMedline Inc.$39.17-0.76%$51.5B
SOLVSolventum Corporation$88.65-0.48%$15.0B
GKOSGlaukos Corporation$244.88-0.34%$14.5B
BDXBecton Dickinson and Company$216.47-0.72%$59.0B
BSXBoston Scientific Corporation$43.69-1.47%$63.3B
BAXBaxter International Inc.$25.54-1.05%$13.2B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier